share_log

HC Wainwright & Co. Maintains Buy on Travere Therapeutics, Maintains $17 Price Target

HC Wainwright & Co. Maintains Buy on Travere Therapeutics, Maintains $17 Price Target

HC Wainwright & Co.維持對Travere Therapeutics的買入,維持17美元的目標股價
Moomoo 24/7 ·  03/13 09:45

HC Wainwright & Co. analyst Ed Arce maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and maintains $17 price target.

HC Wainwright & Co. 分析師埃德·阿爾塞維持Travere Therapeutics(納斯達克股票代碼:TVTX)的買入並維持17美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論